Literature DB >> 24589490

Predictive QSAR modeling of aldose reductase inhibitors using Monte Carlo feature selection.

Chanin Nantasenamat1, Teerawat Monnor2, Apilak Worachartcheewan2, Prasit Mandi3, Chartchalerm Isarankura-Na-Ayudhya4, Virapong Prachayasittikul4.   

Abstract

This study explores the chemical space and quantitative structure-activity relationship (QSAR) of a set of 60 sulfonylpyridazinones with aldose reductase inhibitory activity. The physicochemical properties of the investigated compounds were described by a total of 3230 descriptors comprising of 6 quantum chemical descriptors and 3224 molecular descriptors. A subset of 5 descriptors was selected from the aforementioned pool by means of Monte Carlo (MC) feature selection coupled to multiple linear regression (MLR). Predictive QSAR models were then constructed by MLR, support vector machine and artificial neural network, which afforded good predictive performance as deduced from internal and external validation. The investigated models are capable of accounting for the origins of aldose reductase inhibitory activity and could be utilized in predicting this property in screening for novel and robust compounds.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aldose reductase; Aldose reductase inhibitor; MC-MLR; Monte Carlo; QSAR

Mesh:

Substances:

Year:  2014        PMID: 24589490     DOI: 10.1016/j.ejmech.2014.02.043

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Design of potential anti-tumor PARP-1 inhibitors by QSAR and molecular modeling studies.

Authors:  Zeinab Abbasi-Radmoghaddam; Siavash Riahi; Sajjad Gharaghani; Mohammad Mohammadi-Khanaposhtanai
Journal:  Mol Divers       Date:  2020-03-05       Impact factor: 2.943

2.  Sequential and Mixed Genetic Algorithm and Learning Automata (SGALA, MGALA) for Feature Selection in QSAR.

Authors:  Habib MotieGhader; Sajjad Gharaghani; Yosef Masoudi-Sobhanzadeh; Ali Masoudi-Nejad
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

3.  Discovery of novel 1,2,3-triazole derivatives as anticancer agents using QSAR and in silico structural modification.

Authors:  Veda Prachayasittikul; Ratchanok Pingaew; Nuttapat Anuwongcharoen; Apilak Worachartcheewan; Chanin Nantasenamat; Supaluk Prachayasittikul; Somsak Ruchirawat; Virapong Prachayasittikul
Journal:  Springerplus       Date:  2015-10-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.